Clinical Trial Update: Mild Hypothermia and Supplemental Magnesium Sulfate Infusion in Severe Traumatic Brain Injury (TBI) Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mild hypothermia plus magnesium sulfate infusion in severe traumatic brain injury was terminated. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: United States Department of Defense | Conditions: Traumatic Brain Injury | Phase 2 | Status: TERMINATED | Results posted: 2015-09-30